ID   ATIF1_HUMAN             Reviewed;         106 AA.
AC   Q9UII2; Q5JXL8; Q6IAQ7; Q9BSL9;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-JAN-2026, entry version 194.
DE   RecName: Full=ATPase inhibitor, mitochondrial {ECO:0000305};
DE   AltName: Full=ATP synthase F1 subunit epsilon {ECO:0000305};
DE   AltName: Full=Inhibitor of F(1)F(o)-ATPase;
DE            Short=IF(1);
DE            Short=IF1;
DE   Flags: Precursor;
GN   Name=ATP5IF1 {ECO:0000312|HGNC:HGNC:871}; Synonyms=ATPI, ATPIF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=10664857; DOI=10.1271/bbb.63.2225;
RA   Ichikawa N., Ushida S., Kawabata M., Masazumi Y.;
RT   "Nucleotide sequence of cDNA coding the mitochondrial precursor protein of
RT   the ATPase inhibitor from humans.";
RL   Biosci. Biotechnol. Biochem. 63:2225-2227(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Dai F.Y., Yu L., Yang J., Zheng L.H., Wang X.K., Zhao S.Y.;
RT   "Cloning and sequencing of a novel human cDNA homologous to bovine ATP
RT   synthase inhibitor protein mRNA.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RA   Yu L., Zhang P., Gao J.;
RT   "Cloning and characterization of a novel human gene ASI.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Fetal liver;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 26-42, AND VARIABILITY IN MATURE
RP   CHAIN LENGTH.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective labeling of
RT   protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12110673; DOI=10.1074/jbc.m204538200;
RA   Aggeler R., Coons J., Taylor S.W., Ghosh S.S., Garcia J.J., Capaldi R.A.,
RA   Marusich M.F.;
RT   "A functionally active human F1F0 ATPase can be purified by immunocapture
RT   from heart tissue and fibroblast cell lines. Subunit structure and activity
RT   studies.";
RL   J. Biol. Chem. 277:33906-33912(2002).
RN   [14]
RP   FUNCTION.
RX   PubMed=15528193; DOI=10.1074/jbc.m405947200;
RA   Burwick N.R., Wahl M.L., Fang J., Zhong Z., Moser T.L., Li B.,
RA   Capaldi R.A., Kenan D.J., Pizzo S.V.;
RT   "An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the
RT   activity of angiostatin on the endothelial cell surface.";
RL   J. Biol. Chem. 280:1740-1745(2005).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   FUNCTION.
RX   PubMed=19559621; DOI=10.1016/j.tibs.2009.03.006;
RA   Campanella M., Parker N., Tan C.H., Hall A.M., Duchen M.R.;
RT   "IF(1): setting the pace of the F(1)F(o)-ATP synthase.";
RL   Trends Biochem. Sci. 34:343-350(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   FUNCTION.
RX   PubMed=23135403; DOI=10.1038/nature11536;
RA   Shah D.I., Takahashi-Makise N., Cooney J.D., Li L., Schultz I.J.,
RA   Pierce E.L., Narla A., Seguin A., Hattangadi S.M., Medlock A.E.,
RA   Langer N.B., Dailey T.A., Hurst S.N., Faccenda D., Wiwczar J.M.,
RA   Heggers S.K., Vogin G., Chen W., Chen C., Campagna D.R., Brugnara C.,
RA   Zhou Y., Ebert B.L., Danial N.N., Fleming M.D., Ward D.M., Campanella M.,
RA   Dailey H.A., Kaplan J., Paw B.H.;
RT   "Mitochondrial Atpif1 regulates haem synthesis in developing
RT   erythroblasts.";
RL   Nature 491:608-612(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39 AND SER-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER PHE-25, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   FUNCTION.
RX   PubMed=35926043; DOI=10.1126/science.abm1638;
RA   Wyant G.A., Yu W., Doulamis I.P., Nomoto R.S., Saeed M.Y., Duignan T.,
RA   McCully J.D., Kaelin W.G. Jr.;
RT   "Mitochondrial remodeling and ischemic protection by G protein-coupled
RT   receptor 35 agonists.";
RL   Science 377:621-629(2022).
CC   -!- FUNCTION: Endogenous F(1)F(o)-ATPase inhibitor limiting ATP depletion
CC       when the mitochondrial membrane potential falls below a threshold and
CC       the F(1)F(o)-ATP synthase starts hydrolyzing ATP to pump protons out of
CC       the mitochondrial matrix (PubMed:35926043). Required to avoid the
CC       consumption of cellular ATP when the F(1)F(o)-ATP synthase enzyme acts
CC       as an ATP hydrolase. Indirectly acts as a regulator of heme synthesis
CC       in erythroid tissues: regulates heme synthesis by modulating the
CC       mitochondrial pH and redox potential, allowing FECH to efficiently
CC       catalyze the incorporation of iron into protoporphyrin IX to produce
CC       heme. {ECO:0000269|PubMed:12110673, ECO:0000269|PubMed:15528193,
CC       ECO:0000269|PubMed:19559621, ECO:0000269|PubMed:23135403,
CC       ECO:0000269|PubMed:35926043}.
CC   -!- SUBUNIT: Homodimer; represents the active form and is present at a pH
CC       value below 6.5. Homotetramer; represents the inactive form and is
CC       present at a pH value above 7.0 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9UII2; P01023: A2M; NbExp=3; IntAct=EBI-718459, EBI-640741;
CC       Q9UII2; P07550: ADRB2; NbExp=3; IntAct=EBI-718459, EBI-491169;
CC       Q9UII2; P06576: ATP5F1B; NbExp=5; IntAct=EBI-718459, EBI-356231;
CC       Q9UII2; P28329-3: CHAT; NbExp=3; IntAct=EBI-718459, EBI-25837549;
CC       Q9UII2; G5E9A7: DMWD; NbExp=3; IntAct=EBI-718459, EBI-10976677;
CC       Q9UII2; O75190-2: DNAJB6; NbExp=3; IntAct=EBI-718459, EBI-12593112;
CC       Q9UII2; P50570-2: DNM2; NbExp=3; IntAct=EBI-718459, EBI-10968534;
CC       Q9UII2; P22607: FGFR3; NbExp=3; IntAct=EBI-718459, EBI-348399;
CC       Q9UII2; Q53GS7: GLE1; NbExp=3; IntAct=EBI-718459, EBI-1955541;
CC       Q9UII2; P28799-2: GRN; NbExp=3; IntAct=EBI-718459, EBI-25860013;
CC       Q9UII2; P06396: GSN; NbExp=3; IntAct=EBI-718459, EBI-351506;
CC       Q9UII2; P01112: HRAS; NbExp=3; IntAct=EBI-718459, EBI-350145;
CC       Q9UII2; Q9HAQ2: KIF9; NbExp=3; IntAct=EBI-718459, EBI-8472129;
CC       Q9UII2; O14901: KLF11; NbExp=3; IntAct=EBI-718459, EBI-948266;
CC       Q9UII2; P51608: MECP2; NbExp=3; IntAct=EBI-718459, EBI-1189067;
CC       Q9UII2; I6L9F6: NEFL; NbExp=3; IntAct=EBI-718459, EBI-10178578;
CC       Q9UII2; Q9BVL2: NUP58; NbExp=3; IntAct=EBI-718459, EBI-2811583;
CC       Q9UII2; Q99650: OSMR; NbExp=4; IntAct=EBI-718459, EBI-2804080;
CC       Q9UII2; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-718459, EBI-79165;
CC       Q9UII2; A0A6Q8PF08: PMP22; NbExp=3; IntAct=EBI-718459, EBI-50433196;
CC       Q9UII2; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-718459, EBI-5235340;
CC       Q9UII2; O14656-2: TOR1A; NbExp=3; IntAct=EBI-718459, EBI-25847109;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:12110673}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UII2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UII2-2; Sequence=VSP_041417;
CC       Name=3;
CC         IsoId=Q9UII2-3; Sequence=VSP_041418;
CC   -!- DOMAIN: Forms an alpha-helical dimer with monomers associated via an
CC       antiparallel alpha-helical coiled coil composed of residues 74-106,
CC       leaving each N-terminal inhibitory region (residues 26-52) accessible
CC       for interaction with an F1 catalytic domain. The inhibitory N-terminal
CC       region (residues 26-52) binds the alpha(ADP-bound)-beta(ADP-bound)
CC       (ATP5F1A-ATP5F1B) interface of F1-ATPase, and also contact the central
CC       gamma subunit (ATP5F1C). This dimeric state is favored by pH values
CC       below 7.0, and at higher values the dimers associate to form inactive
CC       homotetramer, where the inhibitory region is occluded, masking its
CC       inhibitory activity (By similarity). {ECO:0000250}.
CC   -!- PTM: Exhibits variability in chain length, mitochondria have distinct
CC       pools of protein cleaved after the 24th, 25th, and 26th amino acid.
CC   -!- SIMILARITY: Belongs to the ATPase inhibitor family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH04955.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB029042; BAA88422.1; -; mRNA.
DR   EMBL; AK316600; BAG38187.1; -; mRNA.
DR   EMBL; DB030607; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL050386; CAI46227.1; -; mRNA.
DR   EMBL; AF114836; AAP97235.1; -; mRNA.
DR   EMBL; AY005470; AAF97495.1; -; Genomic_DNA.
DR   EMBL; AL583540; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BT009849; AAP88851.1; -; mRNA.
DR   EMBL; CR457097; CAG33378.1; -; mRNA.
DR   EMBL; AL353622; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07704.1; -; Genomic_DNA.
DR   EMBL; BC004955; AAH04955.1; ALT_INIT; mRNA.
DR   EMBL; BC009677; AAH09677.1; -; mRNA.
DR   CCDS; CCDS319.1; -. [Q9UII2-1]
DR   CCDS; CCDS320.1; -. [Q9UII2-2]
DR   CCDS; CCDS44096.1; -. [Q9UII2-3]
DR   PIR; JC7175; JC7175.
DR   RefSeq; NP_057395.1; NM_016311.5. [Q9UII2-1]
DR   RefSeq; NP_835497.1; NM_178190.3. [Q9UII2-2]
DR   RefSeq; NP_835498.1; NM_178191.3. [Q9UII2-3]
DR   PDB; 8H9E; EM; 2.53 A; J=26-106.
DR   PDB; 8H9L; EM; 2.61 A; J=26-106.
DR   PDB; 8H9S; EM; 2.53 A; J=26-106.
DR   PDB; 8H9U; EM; 2.61 A; J=26-106.
DR   PDB; 8KI3; EM; 2.89 A; J=26-106.
DR   PDBsum; 8H9E; -.
DR   PDBsum; 8H9L; -.
DR   PDBsum; 8H9S; -.
DR   PDBsum; 8H9U; -.
DR   PDBsum; 8KI3; -.
DR   AlphaFoldDB; Q9UII2; -.
DR   EMDB; EMD-34564; -.
DR   EMDB; EMD-34572; -.
DR   EMDB; EMD-34580; -.
DR   EMDB; EMD-34582; -.
DR   EMDB; EMD-37251; -.
DR   SMR; Q9UII2; -.
DR   BioGRID; 125063; 183.
DR   CORUM; Q9UII2; -.
DR   FunCoup; Q9UII2; 669.
DR   IntAct; Q9UII2; 103.
DR   MINT; Q9UII2; -.
DR   STRING; 9606.ENSP00000335203; -.
DR   TCDB; 3.A.2.1.15; the h+- or na+-translocating f-type, v-type and a-type atpase (f-atpase) superfamily.
DR   GlyGen; Q9UII2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UII2; -.
DR   PhosphoSitePlus; Q9UII2; -.
DR   SwissPalm; Q9UII2; -.
DR   BioMuta; ATPIF1; -.
DR   DMDM; 12585262; -.
DR   jPOST; Q9UII2; -.
DR   MassIVE; Q9UII2; -.
DR   PaxDb; 9606-ENSP00000335203; -.
DR   PeptideAtlas; Q9UII2; -.
DR   ProteomicsDB; 84524; -. [Q9UII2-1]
DR   ProteomicsDB; 84525; -. [Q9UII2-2]
DR   ProteomicsDB; 84526; -. [Q9UII2-3]
DR   Pumba; Q9UII2; -.
DR   TopDownProteomics; Q9UII2-1; -. [Q9UII2-1]
DR   TopDownProteomics; Q9UII2-2; -. [Q9UII2-2]
DR   Antibodypedia; 30912; 235 antibodies from 30 providers.
DR   DNASU; 93974; -.
DR   Ensembl; ENST00000335514.10; ENSP00000335203.5; ENSG00000130770.19. [Q9UII2-1]
DR   Ensembl; ENST00000465645.1; ENSP00000437337.1; ENSG00000130770.19. [Q9UII2-3]
DR   Ensembl; ENST00000497986.5; ENSP00000435579.1; ENSG00000130770.19. [Q9UII2-2]
DR   Ensembl; ENST00000642464.1; ENSP00000496122.1; ENSG00000285390.2. [Q9UII2-2]
DR   Ensembl; ENST00000647074.2; ENSP00000494248.1; ENSG00000285390.2. [Q9UII2-1]
DR   Ensembl; ENST00000647380.1; ENSP00000496605.1; ENSG00000285390.2. [Q9UII2-3]
DR   GeneID; 93974; -.
DR   KEGG; hsa:93974; -.
DR   MANE-Select; ENST00000335514.10; ENSP00000335203.5; NM_016311.5; NP_057395.1.
DR   UCSC; uc001bpp.4; human. [Q9UII2-1]
DR   AGR; HGNC:871; -.
DR   ClinPGx; PA25173; -.
DR   CTD; 93974; -.
DR   DisGeNET; 93974; -.
DR   GeneCards; ATP5IF1; -.
DR   HGNC; HGNC:871; ATP5IF1.
DR   HPA; ENSG00000130770; Low tissue specificity.
DR   MalaCards; ATP5IF1; -.
DR   MIM; 614981; gene.
DR   OpenTargets; ENSG00000130770; -.
DR   VEuPathDB; HostDB:ENSG00000130770; -.
DR   eggNOG; ENOG502S4JP; Eukaryota.
DR   GeneTree; ENSGT00390000006264; -.
DR   HOGENOM; CLU_147479_0_0_1; -.
DR   InParanoid; Q9UII2; -.
DR   OMA; QEVDHHK; -.
DR   OrthoDB; 10045676at2759; -.
DR   PAN-GO; Q9UII2; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9UII2; -.
DR   PathwayCommons; Q9UII2; -.
DR   SignaLink; Q9UII2; -.
DR   SIGNOR; Q9UII2; -.
DR   Agora; ENSG00000130770; -.
DR   BioGRID-ORCS; 93974; 14 hits in 1151 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   ChiTaRS; ATP5IF1; human.
DR   GeneWiki; ATPIF1; -.
DR   GenomeRNAi; 93974; -.
DR   Pharos; Q9UII2; Tbio.
DR   PRO; PR:Q9UII2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9UII2; protein.
DR   Bgee; ENSG00000130770; Expressed in left testis and 98 other cell types or tissues.
DR   ExpressionAtlas; Q9UII2; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0043532; F:angiostatin binding; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IDA:UniProtKB.
DR   GO; GO:0042030; F:ATPase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:CAFA.
DR   GO; GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0140260; F:mitochondrial proton-transporting ATP synthase complex binding; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; TAS:UniProtKB.
DR   GO; GO:0030218; P:erythrocyte differentiation; IBA:GO_Central.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0006783; P:heme biosynthetic process; IBA:GO_Central.
DR   GO; GO:0051882; P:mitochondrial depolarization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IDA:UniProt.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0051346; P:negative regulation of hydrolase activity; IDA:UniProtKB.
DR   GO; GO:1905707; P:negative regulation of mitochondrial ATP synthesis coupled proton transport; ISS:UniProtKB.
DR   GO; GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:1903052; P:positive regulation of proteolysis involved in protein catabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1905091; P:positive regulation of type 2 mitophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:1903578; P:regulation of ATP metabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1903214; P:regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0002931; P:response to ischemia; IDA:UniProt.
DR   FunFam; 1.20.5.500:FF:000004; ATPase inhibitor A, mitochondrial; 1.
DR   FunFam; 1.20.5.500:FF:000003; ATPase inhibitor B, mitochondrial; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 2.
DR   InterPro; IPR007648; ATPase_inhibitor_mt.
DR   PANTHER; PTHR48417; ATP SYNTHASE F1 SUBUNIT EPSILON; 1.
DR   PANTHER; PTHR48417:SF1; ATP SYNTHASE F1 SUBUNIT EPSILON; 1.
DR   Pfam; PF04568; IATP; 1.
DR   SUPFAM; SSF64602; F1 ATPase inhibitor, IF1, C-terminal domain; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Direct protein sequencing;
KW   Mitochondrion; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..25
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:19892738,
FT                   ECO:0007744|PubMed:25944712"
FT   CHAIN           26..106
FT                   /note="ATPase inhibitor, mitochondrial"
FT                   /id="PRO_0000002547"
FT   REGION          26..52
FT                   /note="N-terminal inhibitory region"
FT                   /evidence="ECO:0000250"
FT   REGION          26..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          74..106
FT                   /note="Antiparallel alpha-helical coiled coil region"
FT                   /evidence="ECO:0000250"
FT   COILED          63..106
FT                   /evidence="ECO:0000255"
FT   MOD_RES         39
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         103
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35143"
FT   VAR_SEQ         61..106
FT                   /note="AQSREQLAALKKHHEEEIVHHKKEIERLQKEIERHKQKIKMLKHDD -> HY
FT                   RLCFEISLG (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_041417"
FT   VAR_SEQ         61..106
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041418"
FT   CONFLICT        60
FT                   /note="R -> RR (in Ref. 2; CAI46227)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   106 AA;  12249 MW;  A6144431125D5A86 CRC64;
     MAVTALAART WLGVWGVRTM QARGFGSDQS ENVDRGAGSI REAGGAFGKR EQAEEERYFR
     AQSREQLAAL KKHHEEEIVH HKKEIERLQK EIERHKQKIK MLKHDD
//
